Free Trial

Cogent Biosciences (COGT) Competitors

Cogent Biosciences logo
$7.41 +0.19 (+2.63%)
Closing price 04:00 PM Eastern
Extended Trading
$7.42 +0.01 (+0.20%)
As of 06:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COGT vs. AAPG, SRRK, MTSR, KYMR, VKTX, MOR, CRNX, ALVO, MLTX, and CPRX

Should you be buying Cogent Biosciences stock or one of its competitors? The main competitors of Cogent Biosciences include Ascentage Pharma Group International (AAPG), Scholar Rock (SRRK), Metsera (MTSR), Kymera Therapeutics (KYMR), Viking Therapeutics (VKTX), MorphoSys (MOR), Crinetics Pharmaceuticals (CRNX), Alvotech (ALVO), MoonLake Immunotherapeutics (MLTX), and Catalyst Pharmaceuticals (CPRX). These companies are all part of the "pharmaceutical products" industry.

Cogent Biosciences vs. Its Competitors

Ascentage Pharma Group International (NASDAQ:AAPG) and Cogent Biosciences (NASDAQ:COGT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

Ascentage Pharma Group International's return on equity of 0.00% beat Cogent Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Ascentage Pharma Group InternationalN/A N/A N/A
Cogent Biosciences N/A -149.79%-75.61%

Cogent Biosciences has a consensus target price of $14.43, indicating a potential upside of 94.72%. Given Cogent Biosciences' higher possible upside, analysts plainly believe Cogent Biosciences is more favorable than Ascentage Pharma Group International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ascentage Pharma Group International
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cogent Biosciences
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.75

In the previous week, Cogent Biosciences had 4 more articles in the media than Ascentage Pharma Group International. MarketBeat recorded 5 mentions for Cogent Biosciences and 1 mentions for Ascentage Pharma Group International. Ascentage Pharma Group International's average media sentiment score of 1.52 beat Cogent Biosciences' score of 1.01 indicating that Ascentage Pharma Group International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ascentage Pharma Group International
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Cogent Biosciences
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Ascentage Pharma Group International has higher revenue and earnings than Cogent Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ascentage Pharma Group International$134.35M25.84-$55.54MN/AN/A
Cogent BiosciencesN/AN/A-$255.86M-$1.84-4.03

Summary

Ascentage Pharma Group International beats Cogent Biosciences on 6 of the 10 factors compared between the two stocks.

Get Cogent Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COGT vs. The Competition

MetricCogent BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$822.04M$2.88B$5.54B$8.87B
Dividend YieldN/A2.64%5.39%4.10%
P/E Ratio-4.0321.3126.1719.90
Price / SalesN/A278.47414.67113.66
Price / CashN/A41.4736.1356.90
Price / Book5.617.518.055.38
Net Income-$255.86M-$55.05M$3.15B$248.50M
7 Day Performance4.81%2.45%1.85%2.97%
1 Month Performance32.09%7.33%4.81%6.02%
1 Year Performance-10.07%5.38%34.86%20.39%

Cogent Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COGT
Cogent Biosciences
2.5549 of 5 stars
$7.41
+2.6%
$14.43
+94.7%
-19.2%$822.04MN/A-4.0380Positive News
Analyst Forecast
Analyst Revision
AAPG
Ascentage Pharma Group International
N/A$37.15
-0.6%
N/AN/A$3.26B$134.35M0.00600Positive News
SRRK
Scholar Rock
3.6153 of 5 stars
$33.28
-2.2%
$42.67
+28.2%
+315.3%$3.23B$33.19M-13.15140
MTSR
Metsera
N/A$29.00
-2.0%
$55.00
+89.7%
N/A$3.11BN/A0.0081
KYMR
Kymera Therapeutics
3.1183 of 5 stars
$46.29
+0.9%
$59.82
+29.2%
+43.6%$2.99B$47.07M-14.93170Positive News
Insider Trade
Analyst Revision
VKTX
Viking Therapeutics
4.1658 of 5 stars
$24.86
-4.4%
$87.15
+250.6%
-51.8%$2.92BN/A-21.6220
MOR
MorphoSys
N/A$18.96
flat
N/AN/A$2.86B$238.28M-5.45730
CRNX
Crinetics Pharmaceuticals
3.5845 of 5 stars
$29.91
-0.8%
$74.56
+149.3%
-38.3%$2.82B$1.04M-7.83210
ALVO
Alvotech
3.8724 of 5 stars
$9.13
-2.4%
$18.00
+97.2%
-26.6%$2.82B$491.98M24.681,032
MLTX
MoonLake Immunotherapeutics
2.2666 of 5 stars
$44.87
+3.1%
$78.71
+75.4%
+11.5%$2.78BN/A-19.512Positive News
CPRX
Catalyst Pharmaceuticals
4.9226 of 5 stars
$22.12
-1.6%
$32.83
+48.4%
+34.4%$2.74B$491.73M14.0980Positive News

Related Companies and Tools


This page (NASDAQ:COGT) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners